5
REPORT ON THE 'WORKING OF THE KING INSTITUTE, GUINDY
III. FINANCIAL.
The financial statement for the year under review is supplemented
by the inclusion of indirect charges as per G.O. No. 1144, P.H., dated 13th
August 1924. They are shown in detail in statement No. 3.
The total earning capacity of the Institute for the present year is
estimated at Rs. 5,05,330, and the total expenditure including indirect
charges amounts to Rs. 3,03,135, thus leaving an estimated net profit on
the year's working of Rs. 2,02,195. This figure is in excess of that for the
previous year, and shows that the Institute has earned a handsome profit
for Government during the year. In an Institute of this kind, it is
impossible to assign monetary value to the various kinds of work that
is being carried out. The work of the investigation units in connexion
with malaria, relapsing fever and other diseases, and the results of
experiments for improving the potency of the vaccine lymph, with the
resulting saving of life and expenditure to Government, can never be
shown on paper in money value. If this could be done, the Institute
could undoubtedly claim a very much higher profit on the year's working
than the figure shown above.
IV. SCIENTIFIC.
(i) VACCINE SECTION.
(a). Seed lymph.—The seed lymph used throughout the year was
carried over from the previous year's stock, and has now been maintained
in the Institute for the last four years without any break. Continued
potency has been assured by adopting Nijland's method of alternate
passage of the seed material between rabbit, buffalo and calf. The
vitality of the virus, by this means, can be maintained indefinitely, and
therefore there appears to be no reason why the King Institute should
ever again rely on other Institutes for its supply of seed lymph in order
to commence the season's operations.
(b) Type of lymph issued.— As the result of a prolonged investigation
into the relative merits of glycerine and lanoline lymphs for a climate
like that of Madras, carried out during the years 1921 and 1922, only
glycerine lymph is now issued from this Institute as a routine measure
throughout the Presidency. This entailed the introduction of a special
rotary lancet, a portable sterilizer for it, and other modifications in
the procedure of actual vaccination.
Owing to the improved system of recording, it is now easy to furnish
detailed particulars as to the use to which the lymph issued from the
Institute has been put. The consolidated returns give the following
information as to the number and type of the vaccinations carried out in
the Presidency.
—
Total No. of
cases of lymph
issued.
Percentage of
each type of
vaccination to
total issued.
Percentage of
each type of
vaccination to
total recorded
under primary,
secondary and
revaccinations.
Primary vaccinations *
1,141,818
51.3
72.2
Secondary vaccination
107,473
4.8
6.8
Revaccinations
333,141
14.9
21.0
Results unknown acknowledged
in returns
159,407
7.1
. . .
Lymph unaccounted for
487,726
21.9
...
2,229,565
...
100.0
* Primary vaccination is the vaccination of a person who has never been previously vaccinated, and has not
suffered from an attak of smallpox.
Secondary vaccination is one done on a person who failed to "take" in the first operation.
Revaccination is operation performed on a person who has been already vaccinated successfully or who had
a previous attack of smallpox.
2